Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
07/01/2004 | WO2004012656A3 Thiophene and furan derivatives as prostaglandin agonists and use thereof |
07/01/2004 | WO2003080577A3 Amidoacetonitrile compounds |
07/01/2004 | WO2003045878A8 2,w-diaminocarboxylic acid compounds |
07/01/2004 | US20040127744 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
07/01/2004 | US20040127728 condensation; reduction; catalytic hydrogenation |
07/01/2004 | US20040127726 Method for purifying an organic solvent for the purposes of absorption of maleic acid anhydride |
07/01/2004 | US20040127724 such as 3-aminomethyl-4-thiophen-2-yl-butyric acid; for treating epilepsy, neurodegenerative disorders, depression, anxiety, panic, pain, irritable bowel syndrome, and arthritis |
07/01/2004 | US20040127721 Process for the synthesis of bis-aryl diamidoxime compounds |
07/01/2004 | US20040127720 comprises heterocyclic carbenes; recycling polester/polyamide wastes; by-product inhibition |
07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
07/01/2004 | US20040127576 Estrogen receptor modulators |
07/01/2004 | US20040127549 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
07/01/2004 | US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
07/01/2004 | US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens |
07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
07/01/2004 | US20040127488 For therapy of HIV virus infection in a human |
07/01/2004 | US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
07/01/2004 | US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel |
07/01/2004 | US20040127430 Chiral monophosphorus compounds and their transition metal complexes |
07/01/2004 | US20040127424 Inhibitors of cruzipain and other cysteine proteases |
07/01/2004 | US20040127365 Arylphenyl-substituted cyclic ketoenols |
07/01/2004 | US20040124399 Enantiomorph mixtures |
07/01/2004 | DE10260085A1 Selective extraction of 2-keto-L-gulonic acid from polar solution, especially reaction mixture obtained in preparing ascorbic acid by lactonization, using mixture of tertiary amine and polar organic diluent |
07/01/2004 | DE10257785A1 Isophthalsäurederivate Isophthalic acid derivatives |
07/01/2004 | DE10231890B4 Verfahren zur Abtrennung von Ascorbinsäure aus einem polaren, Ascorbinsäure und 2-Keto-L-gulonsäure enthaltenden Lösungsmittel Process for the separation of ascorbic acid from a polar, ascorbic acid and 2-keto-L-gulonic acid solvent containing |
06/30/2004 | EP1432734A1 Cytokine receptor |
06/30/2004 | EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
06/30/2004 | EP1432680A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
06/30/2004 | EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
06/30/2004 | EP1289978A4 Novel electron acceptors for polymeric thin film waveguide media |
06/30/2004 | EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
06/30/2004 | CN1509279A Process for production of citalopram |
06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
06/30/2004 | CN1509169A Use of enantiomeric pure escitalopram |
06/30/2004 | CN1508134A Anti-cance active substance of cyathocline purpurea and separating and purifying method thereof |
06/30/2004 | CN1508133A Red-rooted salvia root anti-peptic ulcer effective site and preparing process thereof |
06/30/2004 | CN1508129A Method for synthesizing pyrrole amides |
06/30/2004 | CN1508114A Method for extracting active principle of diterpenes |
06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
06/29/2004 | US6756501 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a single step process |
06/29/2004 | US6756500 Subjecting substituted alpha, omega-diene in presence of ruthenium, osmium or molybdenum homogeneous or heterogeneous catalyst to metathesis reaction in presence of ionic liquid to form cyclic compound |
06/29/2004 | US6756404 Autoinducer compounds |
06/29/2004 | US6756378 VLA-4 inhibitor compounds |
06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
06/24/2004 | WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them |
06/24/2004 | WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof |
06/24/2004 | WO2004052841A1 Carbidopa prodrugs and uses thereof |
06/24/2004 | WO2004052839A1 Isophtalic acid derivatives |
06/24/2004 | WO2004052836A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
06/24/2004 | WO2004052816A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity |
06/24/2004 | WO2004026224A3 Process for preparing prostaglandin derivatives and starting materials for the same |
06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
06/24/2004 | WO2003064617A9 Pestalotiopsis microsporia isolates and compounds derived therefrom |
06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/24/2004 | US20040122242 Ruthenium-molybdenum catalyst for hydrogenation in aqueous solution |
06/24/2004 | US20040122241 contacting 3-(hydroxymethyl)tetrahydrofuran or 3-formyltetrahydrofuran with a secondary alcohol in the presence of a hydrous zirconia catalyst |
06/24/2004 | US20040122125 Lactone compounds as novel photoinitiators |
06/24/2004 | US20040122102 compounds are potent ocular hypotensives, and are suitable for the management of glaucoma; they also are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases, gastrointestinal, reproduction disorders etc |
06/24/2004 | US20040122098 useful for treating conditions which arise from or are exacerbated by angiogenesis and also for treating cancer |
06/24/2004 | US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
06/24/2004 | US20040122085 Compounds based on 1-oxoisochroman or - phthalan such as phyllodulcin and hydrangenol; food, beverage and feed additives; alcohol abuse |
06/24/2004 | US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |
06/24/2004 | US20040122007 1-aryl-2-hydroxyethyl amides as potassium channel openers |
06/24/2004 | US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease |
06/24/2004 | US20040121985 Useful as restenosis inhibitors; for reducing the level of protein geranylgeranylation in mammalian cells |
06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
06/24/2004 | US20040119052 Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran |
06/24/2004 | DE10258314A1 New alkoxyimino-substituted biphenylcarboxamide derivatives, useful as pesticides, antimicrobials, herbicides and antimycotics, also their new intermediates |
06/24/2004 | DE10249324A1 Polymerisationsfähige bicyclische Cyclopropanderivate und deren Verwendung zur Herstellung von Dentalmaterialien Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
06/24/2004 | CA2507669A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
06/23/2004 | EP1431296A1 Process for preparing alpha- and beta-methyl-gamma-butyrolactone and 3-methyltetrahydrofuran |
06/23/2004 | EP1431295A1 Process for the preparation of 3-methyltetrahydrofuran |
06/23/2004 | EP1430044A1 Process for the preparation of citalopram |
06/23/2004 | EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
06/23/2004 | EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides |
06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
06/23/2004 | CN1507440A Continuous process for producing L-ascorbic acid |
06/23/2004 | CN1507439A Process for the production of 5-benzyl-3-furfuryl alcohol |
06/23/2004 | CN1507427A Indane compounds with negative dielectric anisotropy |
06/23/2004 | CN1506358A Benzofuran derivative and its prepn and use |
06/23/2004 | CN1506357A Process of preparing coarse vitamin C with glulconic acid |
06/23/2004 | CN1154651C Method for separating analogous organic compounds |
06/23/2004 | CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides |
06/23/2004 | CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation |
06/22/2004 | US6753433 Citalopram; halogenating 5-cyanophthalide to form 2-(halomethyl)-4-cyanobenzoyl halide; reaction with p-fluorophenyl- borane or metal halide; reacting with 3-(dimethylamino)propylmetal halide |
06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
06/22/2004 | US6753426 Antiinflammatory agents; autoimmune disease |
06/22/2004 | US6753346 CETP activity inhibitor |
06/22/2004 | CA2308555C Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof |
06/17/2004 | WO2004051217A2 Process for synthesis bis-aryl diamidoxime compounds |
06/17/2004 | WO2004050795A2 Antioxidant-functionalized polymers |
06/17/2004 | WO2004050667A1 Transition metal complex having diphosphine complex as ligand |
06/17/2004 | WO2004050662A1 Single pot conversion of artemisinin into arteether |